Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LiguaTSE:7090 +0.31%54 Debt-to-Equity is 9.16 as of Mar. 2026, which is 283% above its 10-year median of 2.39. GuruFocus rates TSE:7090 with a GF Score™ of 54/100 and a GF Value™ of 円888.91 (Fairly Valued). The stock has 3 warning signs investors should review. Among 565 Healthcare Providers & Services companies, Ligua ranks worse than 98.94% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Ligua's Debt-to-Equity or its related term are showing as below:
TSE:7090'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.47 Med: 2.39 Max: 9.16
Current: 9.27
During the past 9 years, the highest Debt-to-Equity Ratio of Ligua was 9.16. The lowest was 0.47. And the median was 2.39.
TSE:7090's Debt-to-Equity is ranked worse than 98.94% of 565
companies
in the Healthcare Providers & Services industry
Industry Median: 0.43
vs TSE:7090: 9.27
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Ligua Debt-to-Equity Related Terms
Ligua Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Ligua's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7090 vs HCA, THC, EHC: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Ligua's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ligua Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ligua's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Ligua's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ligua (TSE:7090) has a Debt-to-Equity of 9.16 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Ligua and its competitors. This is 283% above median its historical median of 2.39. Over the past decade, Ligua's Debt-to-Equity has ranged from 0.47 to 9.16. According to the industry distribution chart, Ligua ranks #559 out of 565 companies in the Healthcare Providers & Services industry, placing it in the top 98.9%.
Is Ligua's Debt-to-Equity too high?
Ligua's current Debt-to-Equity of 9.16 is 283% above median its 10-year median of 2.39. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 9.16. The Healthcare Providers & Services industry median Debt-to-Equity is 0.43. Ligua's value of 9.16 is 2030.2% above this industry median. Based on the distribution chart, Ligua ranks #559 out of 565 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ligua has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ligua's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ligua ranks #559 out of 565 companies for Debt-to-Equity. This places Ligua in the lower half of its industry. The industry median Debt-to-Equity is 0.43. Ligua's value of 9.16 is 2030.2% above this benchmark. Historically, Ligua's own Debt-to-Equity has ranged from 0.47 to 9.16 over the past decade. While the company's 10-year median is 2.39 vs. the industry median of 0.43, Ligua has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.43, based on 565 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ligua's current Debt-to-Equity of 9.16 is 2030.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Ligua and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ligua's current Debt-to-Equity is 9.16, which is 283% above median its own 10-year median of 2.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ligua stock overvalued right now?
Based on GuruFocus' analysis, Ligua (TSE:7090) is currently considered Fairly Valued. The stock's GF Value™ is 円888.91, compared to a current price of 円956.00 — trading 7.5% above its estimated fair value. The current Debt-to-Equity is 9.16, which is 283% above median its 10-year median of 2.39 and 2030.2% above the Healthcare Providers & Services industry median of 0.43. Ligua's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Ligua (TSE:7090), the current Debt-to-Equity is 9.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ligua (TSE:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Ligua stock appears to be overvalued.
The current stock price of 円956.00 is trading 7.5% above its estimated GF Value™ of 円888.91.
GuruFocus considers Ligua to be Fairly Valued.
Key valuation signals for TSE:7090:
Debt-to-Equity: 9.16 (283% above median its 10-year median of 2.39)
GF Value™: 円888.91 vs. price of 円956.00 (7.5% above fair value)
Industry Position: 2030.2% above the Healthcare Providers & Services median (#559 of 565)
No single metric tells the full story. See the TSE:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ligua Inc is a consulting company providing management support to the healthcare industry for osteopaths. The company's services include sales office operations such as sales improvement, organizational management, executive education, and recruitment, to corporate management areas such as management of management figures and creation of business plans.
54GF Score
Get the complete analysis for TSE:7090
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7090 has been successfully added to your 
